Does GUSELKUMAB Cause Stent placement? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Stent placement have been filed in association with GUSELKUMAB (TREMFYA). This represents 0.0% of all adverse event reports for GUSELKUMAB.
9
Reports of Stent placement with GUSELKUMAB
0.0%
of all GUSELKUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Stent placement From GUSELKUMAB?
Of the 9 reports, 3 (33.3%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which GUSELKUMAB Alternatives Have Lower Stent placement Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE